Strides Pharma Gets USFDA Nod for Generic Gastrointestinal Drug
By Rediff Money Desk, New Delhi May 22, 2024 15:19
Strides Pharma Science's unit receives USFDA approval to market a generic version of Sucralfate Oral Suspension, a medication used to treat gastrointestinal diseases.
New Delhi, May 22 (PTI) Strides Pharma Science on Wednesday said its unit has received approval from the US health regulator to market a generic medication used in the treatment of gastrointestinal diseases.
Singapore-based Strides Pharma Global Pte. Ltd, has received approval for the generic version of Sucralfate Oral Suspension, 1gm/10 mL, from the US Food & Drug Administration (USFDA), the drug firm said in a statement.
The product is bioequivalent and therapeutically equivalent to AbbVie's Carafate (1gm/10mL).
Sucralfate is used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers.
As per IQVIA, Sucralfate Oral Suspension (1gm/10 mL) had a market size of USD 124 million in the US market.
Shares of the company were trading 6.33 per cent up at Rs 899.75 apiece on the BSE.
Singapore-based Strides Pharma Global Pte. Ltd, has received approval for the generic version of Sucralfate Oral Suspension, 1gm/10 mL, from the US Food & Drug Administration (USFDA), the drug firm said in a statement.
The product is bioequivalent and therapeutically equivalent to AbbVie's Carafate (1gm/10mL).
Sucralfate is used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers.
As per IQVIA, Sucralfate Oral Suspension (1gm/10 mL) had a market size of USD 124 million in the US market.
Shares of the company were trading 6.33 per cent up at Rs 899.75 apiece on the BSE.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- GTL Infrastructure
- 2.93 ( -4.87)
- 226206286
- IFL Enterprises
- 1.30 (+ 4.84)
- 81461564
- Vodafone Idea L
- 16.79 (+ 0.66)
- 67447398
- NCL Research
- 0.95 ( -4.04)
- 31996628
- Franklin Industries
- 3.73 (+ 3.32)
- 21511209
MORE NEWS
Navi Mumbai Airport ILS Signal Testing Begins
The Airports Authority of India (AAI) has begun ILS signal testing at the...
Air India VRS for Non-Flying Staff Ahead of...
Air India has announced a voluntary retirement scheme (VRS) and voluntary separation...
Fisher Groups Oppose WTO Fisheries Subsidy Talks
Small-scale fisher groups from India, Indonesia, and Bangladesh demand WTO keep...